Hangzhou Tigermed Consulting Co., Ltd.
HNGZY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $89 | $0 | $165 | $0 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $0 | -$219 | $0 | $0 |
| Other Non-Cash | -$23 | $430 | $32 | $0 |
| Operating Cash Flow | $66 | $211 | $198 | $0 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$10 | -$53 | -$48 | -$78 |
| Net Acquisitions | -$22 | $0 | -$2 | -$346 |
| Inv. Purchases | -$37 | -$127 | -$748 | -$85 |
| Inv. Sales/Matur. | $105 | $902 | $149 | $1,499 |
| Other Inv. Act. | $1 | -$19 | -$9 | -$5 |
| Investing Cash Flow | $36 | $704 | -$658 | $984 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$125 | -$462 | $236 | -$1,309 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $43 | -$372 | $0 | $0 |
| Dividends Paid | $0 | -$244 | -$27 | -$33 |
| Other Fin. Act. | -$31 | $355 | -$313 | -$88 |
| Financing Cash Flow | -$113 | -$723 | -$104 | -$1,430 |
| Forex Effect | $6 | $9 | $5 | $15 |
| Net Chg. in Cash | -$5 | $201 | -$559 | $87 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $237 | $1,490 | $2,048 | $1,962 |
| End Cash | $232 | $1,690 | $1,490 | $2,048 |
| Free Cash Flow | $56 | $158 | $150 | $440 |